SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9935017
Source:
http://linkedlifedata.com/resource/pubmed/id/9935017
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011849
,
umls-concept:C0013227
,
umls-concept:C0026565
,
umls-concept:C0030705
,
umls-concept:C0038766
,
umls-concept:C0155626
,
umls-concept:C0162577
,
umls-concept:C0439851
,
umls-concept:C0442805
,
umls-concept:C1552596
,
umls-concept:C1947931
pubmed:issue
1
pubmed:dateCreated
1999-2-17
pubmed:abstractText
The purpose of this study was to examine the impact of sulfonylurea drug use on outcome in diabetic patients undergoing direct coronary angioplasty for acute myocardial infarction.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9935017-10483986
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9935017-10716492
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0735-1097
pubmed:author
pubmed-author:BradyP APA
,
pubmed-author:GarrattK NKN
,
pubmed-author:GrillD EDE
,
pubmed-author:HassingerN LNL
,
pubmed-author:HolmesD RDRJr
,
pubmed-author:TerzicAA
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-24
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9935017-Adult
,
pubmed-meshheading:9935017-Aged
,
pubmed-meshheading:9935017-Aged, 80 and over
,
pubmed-meshheading:9935017-Angioplasty, Balloon, Coronary
,
pubmed-meshheading:9935017-Diabetes Mellitus, Type 2
,
pubmed-meshheading:9935017-Diabetic Angiopathies
,
pubmed-meshheading:9935017-Female
,
pubmed-meshheading:9935017-Follow-Up Studies
,
pubmed-meshheading:9935017-Hemodynamics
,
pubmed-meshheading:9935017-Hospital Mortality
,
pubmed-meshheading:9935017-Humans
,
pubmed-meshheading:9935017-Hypoglycemic Agents
,
pubmed-meshheading:9935017-Male
,
pubmed-meshheading:9935017-Middle Aged
,
pubmed-meshheading:9935017-Myocardial Infarction
,
pubmed-meshheading:9935017-Odds Ratio
,
pubmed-meshheading:9935017-Regression Analysis
,
pubmed-meshheading:9935017-Risk
,
pubmed-meshheading:9935017-Sulfonylurea Compounds
,
pubmed-meshheading:9935017-Survival Rate
,
pubmed-meshheading:9935017-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.
pubmed:affiliation
Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA.
pubmed:publicationType
Journal Article